Director – Central Government Affairs
Edwards Lifesciences
Director – Central Government Affairs
Edwards Lifesciences
Develops transcatheter heart valves and devices
The key responsibility of this role is to navigate central Payer’s policy trend and provide insight for access strategy developing, to develop government affairs strategy and conduct related projects via close collaboration with local market access team, market access strategy, tendering team and cross-functional team. The individual will collaborate closely with local Business leaders and will implement and execute and country specific Market Access & Government Affairs programs in alignment with the Business Units imperatives to secure patients' access to Edwards Lifesciences products at optimal conditions and will ensure early input into the access strategy.
How you’ll make an impact:
1. Navigate the policy of central payer’s policy and anticipate the trend then provide independent insight to lead and support access strategy developing. Build good connection with central ministries to expand EW’s impact.
2. Develop and execute central government affairs’ strategy for Edwards Lifesciences China.
3. Response for local market access work in Beijing and Tianjin and other assigned works.
4. Work with JAPAC/global Public Affairs team, as well as cross-functional business partners on the special strategic partnerships/projects.
What you'll need (Required) :
Bachelor's Degree or equivalent in in healthcare-related fields, at least 10 years of experience of market access, health economics and reimbursement, government relation, government affairs or relevant fields
What else we look for (Preferred):
Develops transcatheter heart valves and devices
Edwards Lifesciences focuses on cardiovascular medical technologies, especially transcatheter heart valves. Its products enable repairing or replacing diseased heart valves through minimally invasive procedures rather than open-heart surgery. The company builds on a long history that began with the Starr-Edwards valve and now centers on valve therapies and related diagnostics to treat heart disease. It differentiates itself by specializing in valve technologies and transcatheter approaches, backed by a track record of clinical leadership and global reach. The goal is to improve patient outcomes by providing safer, less invasive valve treatment options for people around the world.
Explore more opportunities at Edwards Lifesciences